Literature DB >> 24646955

A single trial of transcutaneous electrical nerve stimulation reduces chronic neuropathic pain following median nerve injury in rats.

Hwi-Young Cho1, Hye Rim Suh, Hee Chul Han.   

Abstract

Neuropathic pain is a devastating chronic condition and is often induced in the upper limb following nerve injury or damage. Various drugs or surgical methods have been used to manage neuropathic pain; however, these are frequently accompanied by undesirable side effects. Transcutaneous electrical nerve stimulation (TENS) is a safe and non-invasive intervention that has been used to alleviate different types of pain in the clinic, but it is unclear whether TENS can improve chronic neuropathic pain in the upper limb. Thus, the aim of this study was to investigate the effects of a single trial of TENS on chronic neuropathic pain following median nerve injury. Male rats weighing 200-250 g received median nerve-ligation of the right forearm, while the control group received only skin-incision without nerve-ligation. Neuropathic pain-behaviors, including mechanical, cold, and thermal allodynia, were measured for 4 weeks. After the development of chronic neuropathic pain, TENS (100 Hz, 200 µs, sub-motor threshold) or placebo-TENS (sham stimulation) was applied for 20 min to the ipsilateral or contralateral side. Neuropathic pain behavior was assessed before and after intervention. Median nerve-ligation significantly induced and maintained neuropathic pain in the ipsilateral side. TENS application to the ipsilateral side effectively attenuated the three forms of chronic neuropathic pain in the ipsilateral side compared to sham-treated rats (peripheral and central effects), while TENS application to contralateral side only reduced mechanical allodynia in the ipsilateral side (central effect). Our findings demonstrate that TENS can alleviate chronic neuropathic pain following median nerve injury.

Entities:  

Mesh:

Year:  2014        PMID: 24646955     DOI: 10.1620/tjem.232.207

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

1.  Supraspinal neural mechanisms of the analgesic effect produced by transcutaneous electrical nerve stimulation.

Authors:  Yanzhi Bi; Zhaoxing Wei; Yazhuo Kong; Li Hu
Journal:  Brain Struct Funct       Date:  2020-11-24       Impact factor: 3.270

2.  Effects of transcutaneous electrical nerve stimulation on pain in patients with spinal cord injury: a randomized controlled trial.

Authors:  Xia Bi; Hong Lv; Bin-Lin Chen; Xin Li; Xue-Qiang Wang
Journal:  J Phys Ther Sci       Date:  2015-01-09

3.  Late administration of high-frequency electrical stimulation increases nerve regeneration without aggravating neuropathic pain in a nerve crush injury.

Authors:  Hong-Lin Su; Chien-Yi Chiang; Zong-Han Lu; Fu-Chou Cheng; Chun-Jung Chen; Meei-Ling Sheu; Jason Sheehan; Hung-Chuan Pan
Journal:  BMC Neurosci       Date:  2018-06-25       Impact factor: 3.288

Review 4.  Remote Analgesic Effects Of Conventional Transcutaneous Electrical Nerve Stimulation: A Scientific And Clinical Review With A Focus On Chronic Pain.

Authors:  Shai N Gozani
Journal:  J Pain Res       Date:  2019-11-26       Impact factor: 3.133

5.  Transcutaneous Electrical Nerve Stimulation in Rodent Models of Neuropathic Pain: A Meta-Analysis.

Authors:  Jiapeng Huang; Chunlan Yang; Kehong Zhao; Ziqi Zhao; Yin Chen; Tingting Wang; Yun Qu
Journal:  Front Neurosci       Date:  2022-01-31       Impact factor: 4.677

6.  Comparison of the effective intensity of transcutaneous electrical nerve stimulation contralateral to a pain site for analgesia.

Authors:  Hirobumi Kawamura; Morihiro Tsujishita
Journal:  J Phys Ther Sci       Date:  2022-10-01

7.  The Effects of High-Frequency Transcutaneous Electrical Nerve Stimulation for Dental Professionals with Work-Related Musculoskeletal Disorders: A Single-Blind Randomized Placebo-Controlled Trial.

Authors:  Hye Rim Suh; Tae Hoon Kim; Gyeong-Soon Han
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-17       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.